Free News Archives
Latest Issue of OR Manager
February 2025

Joint Commission: Special COVID-19 equipment, utilities ITM survey considerations

Editor's Note The Joint Commission announced June 17 that it has resumed limited survey activities this month, and that scoring of items that are not compliant will not be the primary focus during the COVID-19 public health emergency. However, the Joint Commission says, there are several elements of performance (EPs)…

Read More

By: Judy Mathias
June 18, 2020
Share

CDC: Patients with underlying conditions 12 times as likely to die from COVID-19

Editor's Note Patients with underling conditions, such as heart disease, chronic lung disease, and diabetes were hospitalized six times as often and died 12 times as often from COVID-19 as those without underlying conditions, the Centers for Disease Control and Infection (CDC) reports. Severe outcomes increased with age—the percentages of…

Read More

By: Judy Mathias
June 18, 2020
Share

Cleveland Clinic develops COVID-19 risk calculator

Editor's Note The Cleveland Clinic announced June 15 that its researchers have developed the world’s first model to predict the likelihood of patients testing positive for COVID-19 and their outcomes from the disease. The model was based on data from nearly 12,000 patients in the Cleveland Clinic’s COVID-19 Registry, including…

Read More

By: Judy Mathias
June 18, 2020
Share

Coordinated COVID-19 response helped ‘flatten the curve’ in Washington State

Editor's Note A regional, coalition-guided, multifaceted approach that engaged healthcare systems, long-term care facilities, state and local governments, and organizations to rapidly respond to the COVID-19 outbreak, kept Washington State’s death rate the lowest of all states with major outbreaks, this study finds. Six key factors helped “flatten the curve:”…

Read More

By: Judy Mathias
June 17, 2020
Share

Dexamethasone reduces COVID-19 deaths by one-third

Editor's Note In preliminary results of this study from the University of Oxford, UK, a low-cost steroid, dexamethasone, reduced deaths by up to one third in hospitalized patients with severe respiratory complications of COVID-19. A total of 2,104 patients were randomized to receive dexamethasone 6 mg once per day for…

Read More

By: Judy Mathias
June 17, 2020
Share

COVID-19 threatens entire nervous system

Editor's Note COVID-19 causes a global threat to the entire nervous system, including the brain, spinal cord, and nerves, and neurologic symptoms may appear before symptoms, such as fever, cough, or respiratory problems, finds this study from Northwestern Medicine in Chicago. This analysis found that about half of hospitalized patients…

Read More

By: Judy Mathias
June 16, 2020
Share

Mayo Clinic launches neutralizing antibody test for COVID-19

Editor's Note The Mayo Clinic on June 11 announced that it had launched a new SARS-CoV-2 neutralizing antibody test that will be available to select labs, blood banks, and biopharma clients in late June. The test measures the level of neutralizing antibodies against SARS-CoV-2, the virus that causes COVID-19. Neutralizing…

Read More

By: Judy Mathias
June 16, 2020
Share

Implementation of an elastomeric mask program as a strategy to eliminate N95 use, resterilization

Editor's Note Reusable elastomeric masks provide a more durable, less costly, longer term option than N95 masks for healthcare providers during the COVID-19 pandemic, this study finds. Within 1 month of implementing the elastomeric mask program at the Allegheny Health Network’s nine-hospital system in Pennsylvania and Western New York, the…

Read More

By: Judy Mathias
June 15, 2020
Share

CDC releases updated COVID-19 testing recommendations

Editor's Note The Centers for Disease Control and Prevention (CDC) on June 13 released updated recommendations for COVID-19 testing, including interim testing guidelines for nursing home residents and healthcare personnel. Recommendations also include testing strategies for high-density critical infrastructure workplaces after a COVID-19 case is identified. The consolidated recommendations for…

Read More

By: Judy Mathias
June 15, 2020
Share

Anesthesiologists’, intensive care providers’ exposure to COVID-19 and development of antibodies

Editor's Note Within 6 to 8 weeks of the COVID-19-outbreak, a small proportion of anesthesiologists and intensive care providers reported COVID-19 symptoms after a work-related exposure, and fewer had detectable COVID-19 antibodies, this study finds. Of 105 anesthesiologists and intensive care providers at New York City’s Columbia University Irving Medical…

Read More

By: Judy Mathias
June 11, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat